Comparisons of morphometric measurements and serum insulin-like growth factor concentration in healthy cats and cats with hypertrophic cardiomyopathy

Vicky K. Yang Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA 01536.

Search for other papers by Vicky K. Yang in
Current site
Google Scholar
PubMed
Close
 PhD
,
Lisa M. Freeman Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA 01536.

Search for other papers by Lisa M. Freeman in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
John E. Rush Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA 01536.

Search for other papers by John E. Rush in
Current site
Google Scholar
PubMed
Close
 DVM, MS

Abstract

Objective—To compare morphometric measurements and serum insulin-like growth factor (IGF-1) concentration in cats with and without hypertrophic cardiomyopathy (HCM), and assess the hypothesis that cats with HCM have larger body size and skeletal features and higher serum IGF-1 concentrations than healthy cats.

Animals—25 cats with HCM and 22 healthy control cats.

Procedures—Physical examination and echocardiography were performed to classify cats into the HCM and control groups. Data collected from each cat included diet history, body weight, body condition score, lengths of the humerus and 4th and 12th thoracic vertebrae, heart size, head length and width, and abdominal circumferences. Comparisons of these variables were made between groups.

Results—Body condition score in HCM-affected and control cats did not differ significantly. However, median head width; lengths of the head, 4th and 12th thoracic vertebrae, and humerus; and body weight in the HCM-affected group were significantly greater than values in the control group. Median serum concentration of IGF-1 was not significantly different between groups.

Conclusions and Clinical Relevance—These data suggested that among the study cats, those with HCM were skeletally larger, but not more obese, than healthy cats. Whether this was attributable to differences in early growth or other causes requires additional investigation.

Abstract

Objective—To compare morphometric measurements and serum insulin-like growth factor (IGF-1) concentration in cats with and without hypertrophic cardiomyopathy (HCM), and assess the hypothesis that cats with HCM have larger body size and skeletal features and higher serum IGF-1 concentrations than healthy cats.

Animals—25 cats with HCM and 22 healthy control cats.

Procedures—Physical examination and echocardiography were performed to classify cats into the HCM and control groups. Data collected from each cat included diet history, body weight, body condition score, lengths of the humerus and 4th and 12th thoracic vertebrae, heart size, head length and width, and abdominal circumferences. Comparisons of these variables were made between groups.

Results—Body condition score in HCM-affected and control cats did not differ significantly. However, median head width; lengths of the head, 4th and 12th thoracic vertebrae, and humerus; and body weight in the HCM-affected group were significantly greater than values in the control group. Median serum concentration of IGF-1 was not significantly different between groups.

Conclusions and Clinical Relevance—These data suggested that among the study cats, those with HCM were skeletally larger, but not more obese, than healthy cats. Whether this was attributable to differences in early growth or other causes requires additional investigation.

All Time Past Year Past 30 Days
Abstract Views 95 0 0
Full Text Views 826 562 36
PDF Downloads 357 141 15
Advertisement